Sima P. Porten MD, MPH
Dr. Sima Porten received her undergraduate, doctoral and public health degrees from Northwestern University completing her education in June 2006. She was inducted into the Alpha Omega Alpha Honor Society during medical school and also completed a Howard Hughes Medical Institute-NIH Research Scholars fellowship during that time. She then completed her urology residency training at the University of California, San Francisco where she received the Julius R. Krevans Award for Clinical Excellence. She then completed her Urologic Oncology Fellowship at The University of Texas, MD Anderson Cancer Center. During her fellowship, she was awarded the John Quale Travel Fellowship for her research in Bladder Cancer. Currently, she is part of the multidisciplinary urologic oncology team of the UCSF Helen Diller Family Comprehensive Cancer Center where she continues to pursue her clinical and research interests in bladder cancer, upper tract urothelial cancer, and high-risk prostate cancer.
Dr. Porten’s clinical interests include the diagnosis and treatment of genitourinary malignancy, including minimally invasive approaches to cancer treatment. She is an active member of the American Urological Association (AUA), American Society of Clinical Oncology, Society of Women in Urology, and the Society of Urologic Oncology.
Dr. Porten’s research interests focus mainly in the diagnosis and management of urothelial carcinoma (bladder and upper tract). In studying the biologic basis of urothelial carcinoma using genomic techniques, Dr. Porten hopes to develop new tests and novel therapeutics to bring personalized medicine to patients with bladder cancer.